You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer
|
|---|---|
| Published in |
BMC Cancer, December 2006
|
| DOI | 10.1186/1471-2407-6-285 |
| Pubmed ID | |
| Authors |
Helmut Friess, Jan M Langrehr, Helmut Oettle, Jochen Raedle, Marco Niedergethmann, Christian Dittrich, Dieter K Hossfeld, Herbert Stöger, Bart Neyns, Peter Herzog, Pascal Piedbois, Frank Dobrowolski, Werner Scheithauer, Robert Hawkins, Frieder Katz, Peter Balcke, Jan Vermorken, Simon van Belle, Neville Davidson, Albert Abad Esteve, Daniel Castellano, Jörg Kleeff, Adrien A Tempia-Caliera, Andreas Kovar, Johannes Nippgen |
Mendeley readers
The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 74 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 10 | 14% |
| Student > Ph. D. Student | 9 | 12% |
| Student > Doctoral Student | 8 | 11% |
| Student > Bachelor | 8 | 11% |
| Researcher | 6 | 8% |
| Other | 19 | 26% |
| Unknown | 14 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 21 | 28% |
| Agricultural and Biological Sciences | 10 | 14% |
| Biochemistry, Genetics and Molecular Biology | 7 | 9% |
| Psychology | 6 | 8% |
| Nursing and Health Professions | 4 | 5% |
| Other | 11 | 15% |
| Unknown | 15 | 20% |